In obesity and T2D subjects, the IL-6 signaling pathway in muscle cells has an abnormal function because there is a reduction in the expression of IL-6 receptor and also an abnormal STAT3/suppressor of cytokine signaling 3 (SOCS3) in adipose tissue [35,38]. Here, SOCS3 is linked to type 2 diabetes mellitus.